Early phase clinical trials showed a partial improvement in CFTR-mediated chloride transport in ΔF508-CFTR homozygous subjects with CF (Rubenstein and Zeitlin, 1998; Zeitlin et al., 2002), but the amount of improvement suggested that more efficacious correctors would be necessary to achieve meaningful clinical improvements. Here, CFTR is linked to cystic fibrosis.